Overcoming challenges in scaled manufacturing of iPSC-derived cells
On demand

Overcoming challenges in scaled manufacturing of iPSC-derived cells

Thursday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Overcoming challenges in scaled manufacturing of iPSC-derived cells

This webinar will delve into the challenges of translating workflows into a GMP-compliant environment, specifically focusing on regenerative medicine in cardiovascular diseases. Discussion will focus on the pre-clinical development path, and hurdles related to raw materials supply chain management, and identifying equipment compatible with the execution of novel, compliant manufacturing processes.

Learn how the MACSQuant® Tyto®, with its closed and sterile cell sorting system, is the ideal solution for easily translating workflows from the research bench to clinical manufacturing.

Attend this webinar to learn about:

  • How to ease the translation of flow sorting from RUO to GMP compliance using the MACSQuant Tyto
  • Considerations for developing a process to achieve target final cell product purity
  • Benefits and challenges of working in a quality system during early-stage process development
Alina Steinbach
Alina Steinbach
Expert for Cell Sorting, Miltenyi Biotec

Alina Steinbach joined Miltenyi Biotec in 2017 as a Global Technical Support Specialist for research products and applications following the completion of her PhD and post-doctoral studies in Cancer Immunotherapy at the German Cancer Research Center, Heidelberg. In 2020 she transitioned to her current position as Global Product Manager for flow sorting.

Dave Mann
Dave Mann
CEO, Vascugen

Dave Mann, the CEO of Vascugen, is a leader and cross-functional innovator, marketer, and portfolio manager with over 20 years of experience in the stem cell and pharmaceutical industries in successful startup environments.

Michaela  Diakatou
Michaela Diakatou
Expert for PSCs and MSCs Clinical Applications, Miltenyi Biotec

Michaela Diakatou is the Global Product Manager for PSCs and MSCs Clinical Applications. She completed her PhD in iPSCs and Gene Therapy in 2021 and worked as an Independent Scientific Consultant until her move to Miltenyi Biotec in 2023.

Matthew George
Matthew George
Associate Director of Research, Vascugen

Matthew George, the first Vascugen employee, has over 15 years of pluripotent stem cell experience in academia and industry developing protocols for ESC/iPSC differentiation into cardiac, hematopoietic, hepatic, neural, pancreatic, endothelial and thymic lineages.